Johnson & Johnson JNJ
News
Johnson & Johnson Strikes $850 Million Deal to Boost Dermatology Portfolio
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
J&J scores lowest spread of year on bonds to help fund $13 billion bid for Shockwave
J&J to Sell Remaining Stake in Kenvue Spinoff
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Shockwave Medical Reports First Quarter 2024 Financial Results
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV)
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV)
Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure
Cidara Therapeutics Shares Surge 42% After Re-Acquiring Flu Asset
Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports
Johnson & Johnson's stock falls as profit beats but sales fall slightly short of estimates
Johnson & Johnson on Track for Lowest Close Since November 2020 — Data Talk
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
Trending: Johnson & Johnson 1Q Adjust Earnings Beat Forecasts as Company Raises Dividend